克隆性造血与经导管主动脉瓣植入术后死亡率的关系
该研究对279例接受经导管主动脉瓣植入术的重度退行性主动脉瓣狭窄患者进行DNMT3A和TET2靶向测序,发现33.3%存在CHIP驱动突变,且随年龄增长发生率从25%升至52.9%。携带DNMT3A或TET2突变的患者术后中期全因死亡率显著增加,并伴有促炎性白细胞亚群分布改变。
要点
- 重度主动脉瓣狭窄TAVI患者中CHIP驱动突变常见,发生率达33.3%。
- DNMT3A或TET2突变者TAVI术后中期全因死亡率显著增高。
- 突变携带者存在促炎性T细胞极化或非经典单核细胞增多。
核心结论
- 获得性体细胞突变在重度退行性主动脉瓣狭窄患者中常见,与促炎性白细胞亚群增加相关,并显著增加成功TAVI术后的死亡率。
研究设计与样本
- 对279例接受TAVI的重度主动脉瓣狭窄患者进行DNMT3A和TET2靶向扩增子测序。
主要发现
- 93/279例(33.3%)检出VAF≥2%的DNMT3A或TET2 CHIP驱动突变。
- CHIP发生率随年龄增长从25%(55-69岁)升至52.9%(90-100岁)。
- 突变携带者与无突变者在临床参数、合并动脉粥样硬化疾病、血细胞计数、炎症标志物或手术特征上无差异。
- 携带DNMT3A或TET2突变的患者成功TAVI术后中期全因死亡率 profoundly 增加。
- DNMT3A突变携带者显示促炎性T细胞极化,TET2突变携带者非经典单核细胞增多。
临床怎么用
- 对接受TAVI的重度主动脉瓣狭窄患者,可考虑评估CHIP状态以识别术后高死亡风险人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Clonal haematopoiesis of indeterminate potential (CHIP), defined as the presence of an expanded somatic blood cell clone without other haematological abnormalities, was recently shown to increase with age and is associated with coronary artery disease and calcification. The most commonly mutated CHIP genes, DNMT3A and TET2, were shown to regulate inflammatory potential of circulating leucocytes. The incidence of degenerative calcified aortic valve (AV) stenosis increases with age and correlates with chronic inflammation. We assessed the incidence of CHIP and its association with inflammatory blood cell phenotypes in patients with AV stenosis undergoing transfemoral aortic valve implantation (TAVI). METHODS AND RESULTS: Targeted amplicon sequencing for DNMT3A and TET2 was performed in 279 patients with severe AV stenosis undergoing TAVI. Somatic DNMT3A- or TET2-CHIP-driver mutations with a VAF ≥ 2% were detected in 93 out of 279 patients (33.3%), with an age-dependent increase in the incidence from 25% (55-69 years) to 52.9% (90-100 years). Patients with DNMT3A- or TET2-CHIP-driver mutations did not differ from patients without such mutations in clinical parameters, concomitant atherosclerotic disease, blood cell counts, inflammatory markers, or procedural characteristics. However, patients with DNMT3A- or TET2-CHIP-driver mutations had a profoundly increased medium-term all-cause mortality following successful TAVI. Differential myeloid and T-cell distributions revealed pro-inflammatory T-cell polarization in DNMT3A-mutation carriers and increased pro-inflammatory non-classical monocytes in TET2-mutation carriers. CONCLUSION: This is the first study to show that acquired somatic mutations in the most commonly mutated CHIP-driver genes occur frequently in patients with severe degenerative AV stenosis, are associated with increased pro-inflammatory leucocyte subsets, and confer a profound increase in mortality following successful TAVI.
引用
- Mas-Peiro S, Hoffmann J, Fichtlscherer S, et al. Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation. Eur Heart J. 2020. PMID: 31504400. doi:10.1093/eurheartj/ehz591
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。